Alyeska Investment Group
MDLN

Alyeska Investment Group’s Medline Inc MDLN Stock Holding History

Alyeska Investment Group’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$269M Buy
6,809,122
+3,871,733
+132% +$156M 0.69% 21
2026
Q1 		$131M Buy
2,937,389
+1,737,389
+145% +$76.7M 0.37% 65
2025
Q4 		$50.4M Buy
+1,200,000
New +$50.7M 0.14% 181

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Alyeska Investment Group's MDLN Position: Q2 2026 in Review

Alyeska Investment Group increased its Medline Inc (MDLN) stake by 132% in Q2 2026, buying an estimated $156M and bringing the position to 6,809,122 shares worth $269M. The position accounts for 0.69% of the portfolio, ranked #21.

Alyeska Investment Group first reported a position in MDLN in Q4 2025 and has held it in 3 quarters since. 408 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Alyeska Investment Group held 6,809,122 shares of Medline Inc worth $269M as of Q2 2026.
  • Alyeska Investment Group bought 3,871,733 Medline Inc shares in Q2 2026, an estimated $156M.
  • Medline Inc made up 0.69% of Alyeska Investment Group's portfolio in Q2 2026, its #21 holding.
  • Alyeska Investment Group first reported a position in Medline Inc in Q4 2025 and has held it in 3 quarters since.
  • 408 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.